PharmStockPharmacy Stock

Movfor
Movfor

4.39
Used to address viral infections, this generic medicine interferes with the replication process of specific infectious organisms to limit their spread within the body.
Ingredient
Molnupiravir
Category
Antivirals
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Molnupiravir
Reference Brand
Molnupiravir
Product Origin
Generic Brand
Product Manufacturer
Hetero Healthcare
Product Form
Capsule
Regulatory Classification
Prescription Only Medicine
Primary Category
Antivirals
Product Category
Nucleoside Analog Antiviral
Pharmacological Class
Antiviral Agent
Manufacturer Description
Indicated to address acute viral replication to manage mild-to-moderate infections and alleviate respiratory progression risk.
Mechanism of Action
Incorporates into viral RNA, causing widespread replication errors that halt viral replication in tissues.
Route of Administration
Oral
Onset Time
24–48 hours
Duration
12 hours
Contraindications
Pregnancy, Hypersensitivity to molnupiravir
Severe Adverse Events
Anaphylaxis — requires immediate medical attention
Common Side Effects
Diarrhea, Nausea, Dizziness
Uncommon Side Effects
Headache, Rash, Vomiting
Pregnancy Safety Warnings
TGA Category D: High risk of fetal toxicity. Strictly contraindicated in pregnancy. Breastfeeding: Avoid.
Age Restrictions
Approved for adults over eighteen years.
Storage Guidelines
Store below 25°C.
Information related to Movfor is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to access BPH Treatment Australia - Buy Tamsulosin AU